These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 37452431)

  • 1. Pathogenesis of miR-155 on nonmodifiable and modifiable risk factors in Alzheimer's disease.
    Liu JJ; Long YF; Xu P; Guo HD; Cui GH
    Alzheimers Res Ther; 2023 Jul; 15(1):122. PubMed ID: 37452431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs as a New Target for Alzheimer's Disease Treatment.
    Shademan B; Avci CB; Karamad V; Sogutlu F; Nourazarian A
    Microrna; 2023; 12(1):3-12. PubMed ID: 36173083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    Chum PP; Hakim MA; Behringer EJ
    J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs as Therapeutic Tools in Alzheimer's Disease.
    Lee CY; Ryu IS; Ryu JH; Cho HJ
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of Alzheimer's disease.
    Liang C; Zou T; Zhang M; Fan W; Zhang T; Jiang Y; Cai Y; Chen F; Chen X; Sun Y; Zhao B; Wang Y; Cui L
    Theranostics; 2021; 11(9):4103-4121. PubMed ID: 33754051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-335-5p Inhibits β-Amyloid (Aβ) Accumulation to Attenuate Cognitive Deficits Through Targeting c-jun-N-terminal Kinase 3 in Alzheimer's Disease.
    Wang D; Fei Z; Luo S; Wang H
    Curr Neurovasc Res; 2020; 17(1):93-101. PubMed ID: 32003672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
    Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
    Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA Dysregulation in Alzheimer's Disease.
    Putteeraj M; Fairuz YM; Teoh SL
    CNS Neurol Disord Drug Targets; 2017; 16(9):1000-1009. PubMed ID: 28782488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Expression of microRNA-1273g-3p Contributes to Alzheimer's Disease Pathogenesis by Regulating the Expression of Mitochondrial Genes.
    Kim SH; Choi KY; Park Y; McLean C; Park J; Lee JH; Lee KH; Kim BC; Huh YH; Lee KH; Song WK
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-106b inhibits tau phosphorylation at Tyr18 by targeting Fyn in a model of Alzheimer's disease.
    Liu W; Zhao J; Lu G
    Biochem Biophys Res Commun; 2016 Sep; 478(2):852-7. PubMed ID: 27520374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs Modulate the Pathogenesis of Alzheimer's Disease: An In Silico Analysis in the Human Brain.
    Gugliandolo A; Chiricosta L; Boccardi V; Mecocci P; Bramanti P; Mazzon E
    Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32846925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-140 silencing represses the incidence of Alzheimer's disease.
    Liang C; Mu Y; Tian H; Wang D; Zhang S; Wang H; Liu Y; Di C
    Neurosci Lett; 2021 Jul; 758():135674. PubMed ID: 33529652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target.
    Zhang M; Bian Z
    Front Neurosci; 2021; 15():687973. PubMed ID: 34108863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of microRNAs in the pathophysiology of human central nervous system: A focus on neurodegenerative diseases.
    Rezaee D; Saadatpour F; Akbari N; Zoghi A; Najafi S; Beyranvand P; Zamani-Rarani F; Rashidi MA; Bagheri-Mohammadi S; Bakhtiari M
    Ageing Res Rev; 2023 Dec; 92():102090. PubMed ID: 37832609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA modulation is a potential molecular mechanism for neuroprotective effects of intranasal insulin administration in amyloid βeta oligomer induced Alzheimer's like rat model.
    Bazrgar M; Khodabakhsh P; Dargahi L; Mohagheghi F; Ahmadiani A
    Exp Gerontol; 2022 Jul; 164():111812. PubMed ID: 35476966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of P-tau/Aβ42 in the cerebrospinal fluid with blood microRNAs in Alzheimer's disease.
    Jia L; Zhu M; Yang J; Pang Y; Wang Q; Li Y; Li T; Li F; Wang Q; Li Y; Wei Y
    BMC Med; 2021 Nov; 19(1):264. PubMed ID: 34775974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.